Previous reports have discussed the rates of morbidity and mortality associated with DBS lead placement. 26 The risk of intracranial hemorrhage during DBS surgery is 0.7-3.3% per lead 5, 6 ,26 compared with 3.9% for all functional stereotactic procedures. 1, 5, 7, 8, 14, 17, 22, 24, 26 This suggests that DBS-specific complications, of which MR imagingassociated complications would be one, do not occur at a higher rate. However, the latter have rarely been discussed, and in fact a recent review of a large series of cases did not reveal any MR imaging-related complications. 15 In the present study, we provide a retrospective review of a subset of our patients to examine the safety of MR imaging in patients with implanted DBS electrodes. We examined our patients who underwent staged DBS procedures to look for MR imaging evidence of MR imaging-induced findings. These patients each underwent 3 MR imaging exposures of the first implanted DBS lead. The first MR imaging exposure occurred within 24 hours of the initial DBS lead implantation. Findings from this MR imaging session, although most likely related to acute insertional effects, could arguably be contributed to by the effects of the MR imaging itself. The second MR imaging session occurred during preoperative planning for implantation of the contralateral DBS lead, and allowed us to evaluate for new findings related to the combination of DBS insertion and MR imaging-induced effects on the first DBS lead. However, it also provided another MR imaging exposure of the first DBS lead, separated from any acute insertional effects of lead placement. The third MR imaging exposure occurred within 24 hours after the second lead was placed. Although it provided a first exposure of the newly inserted second DBS lead, more importantly it allowed us to examine the acute adverse effects of the second imaging session on the first DBS lead, free from confounding effects of insertion (Fig. 1) . Additionally, we reviewed the clinical course of these patients to evaluate whether there were any new neurological deficits related to the first DBS implantation (such as contralateral paresis) that presented after the delayed MR imaging exposures, and therefore removed from the insertional effects.
Methods

Patient Characteristics
Bilateral DBS procedures performed at Emory University Hospital between February 1997 and August 2006 were included in this study. Sixty-four patients, 42 men and 22 women, with a mean age (± SD) of 60 ± 13 years with unilateral DBS devices underwent contralateral DBS insertion into the subthalamic nucleus (in 30 patients), globus pallidus internus (in 23 patients), ventralis intermedius nucleus of the thalamus (10 patients), or zona incerta (1 patient) for the treatment of Parkinson disease (in 46 patients), essential tremor (in 9), dystonia (in 7), or cerebellar outflow tremor (in 2 patients; Table 1 ).
Magnetic Resonance Imaging
Subsequent to first DBS placement, 3 separate MR imaging sessions were performed in each patient: the first immediately after the first DBS placement, the second prior to the contralateral second DBS placement, and the third immediately after the second DBS placement. All MR imaging was performed on a General Electric (Signa), Philips (Achieva), or Siemens (Symphony) magnet with a receive-only head coil with SAR 0.1-0.8 W/ kg. The first and third sessions (acute postoperative studies) generally consisted of the following sequences: axial T1-weighted spin echo, axial inversion recovery FSE, and coronal T2-weighted FSE. 15 The second session (preoperative) always consisted of an axial T1-weighted spin echo and axial inversion recovery FSE. In addition, a total of 34 diffusion-weighted studies were performed (Table 2) . One hundred and ninety-two MR imaging sessions were performed in total. The average time between the first and second session was 19.4 months (1-76 months), and between the second and third was 14.7 hours (range 1-168 hours). The average clinical follow-up period was 3.67 years (range 58 days to 8.8 years).
Potential MR imaging-or operation-induced findings were initially reviewed from original radiology reports and then confirmed by a separate review of the associated MR images by a neurosurgical resident (V.C.) and an attending functional neurosurgeon (R.E.G.). All sequences were then rereviewed both by a neurosurgeon (V.C.) and a neuroradiologist (C.H.) for any additional findings.
Surgical Procedure
All patients in this series underwent staged implantation of their DBS electrodes using standard stereotactic techniques and microelectrode mapping. 10 After implantation, the DBS lead was fixed in place with the Medtronic bur hole ring and cap, the Stim-loc assembly (IGN, Medtronic), or the Medtronic bur hole ring and methylmethacrylate. The extracranial portion of the lead was coiled and inserted in a subgaleal pocket lateral to the bur hole, with the end of the lead covered by the provided cap or-previous to its availability-the provided percutaneous cable cut after the connection to the DBS lead. Immediate postoperative MR imaging was usually performed on the same day as surgery or early the next day, prior to implantation of the extension cable and IPG.
The extension cable and IPG (Itrel II or Soletra, Medtronic) were inserted within several weeks after the first or second DBS lead implantation, in which case the coils in the extracranial portion of the DBS lead were left unperturbed and the IPG was implanted in a subcutaneous pocket in the infraclavicular region. Thus, the preand postoperative MR imaging for the second DBS procedure was performed with the first DBS extension cable and IPG in place, in which case the IPG was set to 0.0 V and turned off prior to imaging.
Chart Review
We retrospectively reviewed the charts of all the patients included in this series for clinical complications associated with the DBS procedure. Each complication was examined for possible relationship to the MR imaging aspect of the procedure. This study was approved by the Emory University Institutional Review Board.
Results
All MR images were reviewed. Thirty-one findings were apparent on MR imaging, including blood along the catheter tract in 11 patients (5.7%), edema in 7 (3.6%), focal intraparenchymal hemorrhage in 6 (3.1%), intraventricular hemorrhage in 4 (2.1%), infarct in 1 (0.5%), subdural hygroma in 1 (0.5%), and sulcal subarachnoid blood in 1 patient (0.5%). Of these, 22 were new findings of hemorrhage (Fig. 2) . All of these MR imaging-detected findings were present on the MR images obtained immediately after insertion of the first DBS, or from the third imaging session, obtained immediately after and on the side of the second DBS lead implantation (Table 3) . In contrast, there were no instances of new MR imaging-apparent findings detected during the second imaging session or on the third in relation to the first DBS procedure. Encephalomalacia surrounding the first DBS lead was noted on long-term MR imaging sequences in 8 cases (4.2% of all imaging sequences). This pattern is consistent with insertional injury and inconsistent with MR imaging-induced complications.
With regard to clinical effects, no patient reported or was found to have neurological findings related to the first DBS side after preoperative or postoperative MR imaging scans performed for the second DBS procedure.
Discussion
Magnetic resonance imaging is useful in the postoperative setting to determine DBS lead location (which informs device programming and practice-based learning) and potential complications, and also to evaluate disease progression or new neurological (and other) conditions. Given its usefulness, it is important to continue to examine and improve the safety of MR imaging rather than to eliminate it altogether. 12 Recent changes in the manufacturer's recommendations, not based on scientific data, are to use MR imaging systems operating at 1.5-T, a transmitreceive type radiofrequency head coil, and SAR not to exceed 0.1 W/kg, instead of the previous 0.4 W/kg, in the head.
2, 3 In order to minimize exposure of the lead/neurostimulator system to the MR imaging radiofrequency fields, whole-body radiofrequency coils and receive-only head coils are not recommended However, all MR images in this series were obtained with a receive-only head coil, with the SAR up to 0.8 W/kg. Nevertheless, after critical evaluation of images obtained after the first DBS, before the second DBS, and after the second DBS, no MR imaging-related injury was observed. All MR imagingapparent findings were seen immediately after DBS insertion, and there were no new findings after imaging of previously implanted leads. Moreover, there were no new clinical findings with respect to the first DBS side after 2 closely spaced sessions of delayed MR imaging. These data provide strong evidence for the safety of postoperative MR imaging in patients with implanted DBS electrodes, even when imaging is performed with receiveonly head coils.
Heating of the DBS electrode is an important concern when patients with implanted brain stimulation devices undergo MR imaging. Although stereotactic CT scans provide high spatial accuracy and can be registered to preoperative volumetric MR sequences, postoperative MR imaging is superior with respect to local brain anatomy, and avoids possible inaccuracies associated with rigid registrations in the presence of brain shift. 11, 13 In addition, patients with new neurological findings are best evaluated with MR imaging. Thus, despite the potential risks associated with MR imaging in these patients, there are substantial benefits that compel a more complete analysis of the real versus potential imaging-related risks.
The results of in vitro studies suggest that the temperature increases the most within the first minute and then reaches a steady state temperature change of 2.3° to 7.1°C (transmit-receive head coil) within 15 minutes. 4 Whether this temperature change, if it in fact occurs in vivo, is sufficient to cause a permanent lesion is not known. Because we have not seen any heat-related injury in vivo, we suspect that the brain's dynamic cerebral blood and cerebrospinal fluid flow allows for prompt diffusion of any heat generated by DBS electrodes exposed to MR imaging-generated radiofrequencies when performed as we have described. Only 1 case has been reported of a substantial permanent lesion arising after lumbar MR imaging in a patient with a bilateral subthalamic nucleus DBS system. 12 Interestingly, the patient experienced an intraparenchymal lesion near the electrode tip on 1 side, in which the IPG was implanted in the abdominal region, whereas on the contralateral side in which the IPG was in the more typical subclavicular region, there was no lesion. Although the temperature change in that case is not known, it is certainly reasonable to conclude that it was sufficient to cause the lesion. This case is further notable for its differences and similarities with our series. Their study differed from ours in that they used 1.0-T MR imaging to perfom lumbar MR imaging. In addition, the IPG in this patient was located on the affected side in the abdomen rather than the infraclavicular region, and they possibly used fewer extracranial and/or infraclavicular coils to accommodate a longer distance to the IPG. These differences may have exposed a greater length of conductive wire to MR-related radiofrequency signals, and induced a greater degree of heating of the DBS lead on the affected side. Moreover, the presence of the ex- T2-weighted (A-D, G, and H) and FLAIR (E) and hemosiderin (F) imaging sequences demonstrating insertional adverse effects. A and B: Examples of edema (arrow) surrounding the first DBS lead in the subcortical region on the postoperative MR images. That this was not the result of MR imaging itself is supported by the observation of edema only immediately after electrode implantation, either on the first set of MR images or the images obtained immediately after the second DBS insertion, but never on the second set, performed months after the first insertion. The edema shown in panel B (arrow) surrounds the acutely implanted DBS, and was never seen surrounding the chronically implanted lead. C: Example of subcortical hemorrhage (arrow) associated with acute lead implantation as seen during the first MR imaging session. Again, this was not the result of MR imaging because it was only seen on the first or third imaging sessions, and never in the second set. D: Image obtained immediately after placement of the second lead in the same patient as in panel C. Again, there is hemorrhage associated with the acutely implanted second lead on the patient's right side, whereas the site of the chronically implanted first lead (left side) now manifests encephalomalacic changes (arrow). Note also in panels A-D that the MR imaging-apparent changes surround the insulated part of the electrode rather than the exposed lead array where possible MR imaging-induced currents would flow. E and F: The small hemorrhage seen in panels E (FLAIR sequence) and F (hemosiderin sequence) is around the acutely implanted second DBS electrode array (arrows), but was never seen surrounding the chronically implanted array. G and H: Positive control images depicting what MR imaging-induced changes might look like. This patient underwent radiofrequency ablation delivered through the left DBS electrode, which induced a large region of perielectrode edema (arrows) and ultimately necrosis. tracranial coils in our cases may have acted as a "choke" to prevent current flow into the tip of the DBS electrode, as discussed previously. 16 In contrast, both the index case and our series were performed using a receive-only head coil and a whole-body transmit coil with SAR > 0.1 W/ kg. It seems unlikely that the use of the whole-body coil and higher SAR setting, in isolation, were the critical factors that induced the lesion in this reported case. These deviations from the recommendations, the presence of the extended length of wire exposed to radiofrequency as a result of the abdominal placement, and the possibly fewer or no coils in the wire to choke the current flow probably combined to induce the critical lesion. This highlights the importance of avoiding body MR imaging in the context of abdominal IPG placement.
The incidence of post-DBS edema has not been previously reported in the literature, and in most cases may be related to insertional effects or conceivably to postoperative MR imaging. In noting this finding in 7 cases in the immediate postoperative period, and no cases after imaging of an electrode implanted months to years previously, we conclude that the edema results solely from microelectrode and/or DBS-induced injury. In 8 other instances, encephalomalacia around the electrode secondary to presumed gliosis was noted on follow-up imaging. As expected, encephalomalacia that was noted on the second set of MR images persisted on the third. In 1 case, the patient had had an ablative procedure performed by intentionally subjecting a DBS electrode to radiofrequency currents prior to its removal (Fig. 2) . Most of these cases of encephalomalacia occurred after documented intraparenchymal hemorrhage or edema on immediate MR imaging following the first or second lead placement. Recent pathological studies have demonstrated that DBS does not cause damage to the adjacent tissue, apart from mild gliosis around the implanted electrode track. 12, 26 Blood tracking along the electrode is a common finding on immediate postoperative MR images, and is probably the result of subdural blood tracking along the distal catheter tract. The rate of intracerebral and intraventricular hemorrhage we report in the present study is lower than most published results. 6 One instance of acute infarct was noted 2 days after the second DBS placement and confirmed on repeated MR imaging studies obtained 2 weeks thereafter. Umemura and colleagues 26 reported on their experience with 1 patient with cerebral venous infarction, and Novak et al. 16 described 2 additional cases of subcortical ischemia secondary to DBS electrode placement. Such injuries may have occurred through direct injury of the perforating arteries, or indirectly through vasospasm induced by direct mechanical stimulation, edema, or electrical stimulation. 16 Presently, SAR is recommended not to exceed 0.1 W/ kg in the head, and to limit the gradient dB/dt field to 20-T/second. Whereas the prior recommendation of SAR below 0.4 W/kg was a reasonable parameter for goodquality imaging, 15 and several MR scanners have been tested with this SAR and found safe to use with the proper precautions, the present recommendations limit the quality and type of imaging that can be accomplished. Moreover, the calculation of SAR varies based on the model of the MR system and the software version running on the scanner, so any recommendations in this regard must be carefully applied. 3, 15, 18 Active investigation is underway to attempt to standardize the SAR. In an in vitro model, Baker et al. 4 noted that console-reported SAR does not appear to be a reliable index of DBS electrode heating. In a recent retrospective report, Larson et al. 15 analyzed their large series of 1071 MR imaging events of 746 DBS systems in 405 patients with SAR always set > 0.1 W/ kg, up to 3 W/kg, and with various receive-only (body transmit) or transmit-receive head coils. Although they did not specifically examine the MR imaging scans in a serial fashion as we have done, they did not note any MR imaging-related complications. In combination with our series, it appears reasonable to conclude that the recommended SAR of 0.1 W/kg-which markedly diminishes scan quality, thus limiting its usefulness-is far too conservative. Similarly, the use of a receive-only head coil (as used in all of the patients in the present study) appears not to be the critical factor. However, given the widespread availability of transmit-receive head coils and the added margin of safety they confer, especially in the setting of abdominal IPG placement, like others we now exclusively perform imaging in our patients in this manner.
Conclusions
This retrospective MR imaging-based study supports the safety of MR imaging in patients with implanted DBS systems, at least when performed in the manner we have described here, and with the configuration of the implanted devices we used. Because the indications for DBS continue to expand, it is likely that postoperative MR imaging will remain an important clinical tool. Further prospective studies to definitively evaluate its safety are warranted.
